Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$9.26B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  IART
Integra LifeSciences Holdings
IART
57 / 100
$28.90arrow_drop_down1.63%-$0.48

Performance History

Stocklytics logo
Key Stats
Open$29.12
Prev. Close$29.38
EPS0.84
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap2277891840.00
PE Ratio34.40
LOWHIGH
Day Range28.72
29.38
52 Week Range27.85
59.10
Ratios
P/B Ratio1.62
Revenue$1.54B
Operating M. %19.12%
Earnings$67.74M
Earnings Growth %-62.48%
EBITDA Margin %24.88%
ROE %3.99%
EPS0.84

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

57vs 56. Market Avg.

All Score 57 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

IARTMARKET
Value6440
Quality4840
Ownership017
Growth4045
Dividends-38
check_circle

Integra LifeSciences Holdings's Price discount from 1 year high of 50.07% is great compared to market average of 18.05%. This indicates IART could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$729.60
24H (%)arrow_drop_down2.15%
24H ($)-$16.09
MARKET CAP$695.32B
PRICE$484.11
24H (%)arrow_drop_down0.42%
24H ($)-$2.06
MARKET CAP$452.88B
PRICE$147.97
24H (%)arrow_drop_down1.06%
24H ($)-$1.59
MARKET CAP$359.34B
PRICE$126.53
24H (%)arrow_drop_down0.27%
24H ($)-$0.34
MARKET CAP$321.39B

About Integra LifeSciences Holdings (IART)

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Jan De Witte
Headquarters
Princeton
Employees
3722
Exchange
NASDAQ
add Integra LifeSciences Holdings to watchlist

Keep an eye on Integra LifeSciences Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the 52-week high and low for Integra LifeSciences Holdings (IART)?

For Integra LifeSciences Holdings (IART), the 52-week high is $59.1, which is 104.5% from the current price. The 52-week low is $27.85, the current price is 3.77% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
What is Integra LifeSciences Holdings's (IART) price per share?

The current price per share for Integra LifeSciences Holdings (IART) is $29.03. The stock has seen a price change of -$0.48 recently, indicating a -1.63% change. This reflects the stock's recent market performance and investor sentiment.

help
Is Integra LifeSciences Holdings (IART) a growth stock?

Integra LifeSciences Holdings (IART) has shown an average price growth of -24.69% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Integra LifeSciences Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Integra LifeSciences Holdings (IART) stock price performance year to date (YTD)?

As of the latest data, Integra LifeSciences Holdings (IART) has a year-to-date price change of -33.21%. Over the past month, the stock has experienced a price change of -13.45%. Over the last three months, the change has been -30.19%. Over the past six months, the figure is -22.31%. Looking at a longer horizon, the five-year price change stands at -43.71%.

help
Is Integra LifeSciences Holdings (IART) a profitable company?

Integra LifeSciences Holdings (IART) has a net income of $67.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 57.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 19.12% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.54B, although specific revenue growth data is currently not available. The gross profit is $888.39M. Operating income is noted at $174.08M. Furthermore, the EBITDA is $255.96M.

help
What is the market capitalization of Integra LifeSciences Holdings (IART)?

Integra LifeSciences Holdings (IART) has a market capitalization of $2.28B. The average daily trading volume is 935.32K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.